Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study

  1. Podzamczer, D.
  2. Rozas, N.
  3. Domingo, P.
  4. Miralles, C.
  5. Van den Eynde, E.
  6. Romero, A.
  7. Deig, E.
  8. Knobel, H.
  9. Pasquau, J.
  10. Antela, A.
  11. Clotet, B.
  12. Geijo, P.
  13. Rodríguez de Castro, E.
  14. Casado, M.A.
  15. Muñoz, A.
  16. Casado, A.
Revue:
Current HIV Research

ISSN: 1873-4251 1570-162X

Année de publication: 2018

Volumen: 16

Número: 6

Pages: 425-435

Type: Article

DOI: 10.2174/1570162X17666190212163518 GOOGLE SCHOLAR

Objectifs de Développement Durable